Patents by Inventor Laurent Chofflon

Laurent Chofflon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220387327
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phophate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Application
    Filed: August 18, 2022
    Publication date: December 8, 2022
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.
    Inventors: Laurent CHOFFLON, Erik PHILIPP
  • Patent number: 11446251
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Grant
    Filed: December 16, 2021
    Date of Patent: September 20, 2022
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd.
    Inventors: Laurent Chofflon, Erik Philipp
  • Patent number: 11446252
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Grant
    Filed: December 16, 2021
    Date of Patent: September 20, 2022
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd.
    Inventors: Laurent Chofflon, Erik Philipp
  • Publication number: 20220110875
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Application
    Filed: December 16, 2021
    Publication date: April 14, 2022
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.
    Inventors: Laurent CHOFFLON, Erik PHILIPP
  • Publication number: 20220110874
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Application
    Filed: December 16, 2021
    Publication date: April 14, 2022
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.
    Inventors: Laurent CHOFFLON, Erik PHILIPP
  • Patent number: 11234937
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: February 1, 2022
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd.
    Inventors: Laurent Chofflon, Erik Philipp
  • Patent number: 11234938
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: February 1, 2022
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd.
    Inventors: Laurent Chofflon, Erik Philipp
  • Publication number: 20200222328
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Application
    Filed: March 16, 2020
    Publication date: July 16, 2020
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.
    Inventors: Laurent CHOFFLON, Erik PHILIPP
  • Publication number: 20200222327
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Application
    Filed: March 16, 2020
    Publication date: July 16, 2020
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.
    Inventors: Laurent CHOFFLON, Erik PHILIPP
  • Patent number: 10624855
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: April 21, 2020
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd.
    Inventors: Laurent Chofflon, Erik Philipp
  • Publication number: 20170143634
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Application
    Filed: November 26, 2014
    Publication date: May 25, 2017
    Inventors: Laurent Chofflon, Eric Philipp